InScope – December 2022: Letter from physician leaders

The advent of MRI scanning of the brain and spinal cord was a giant leap forward in improving the ability to diagnose multiple sclerosis with greater sensitivity and reliability.

Growing the surgical oncology programs at Providence Cancer Institute is a testament to our commitment to providing research-focused, comprehensive services and improving outcomes for patients.

During winter months when the days are shorter and darker, both postpartum depression and baby blues may be more difficult.

A study led by Dr. Christopher Darus may offer hope to women with persistent endometrial cancer. Currently, the prognosis is poor for women with this form of cancer.

Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.

Being able to assess the level of fibrosis and make appropriate referrals is important in the care of patients with Steatotic Liver Disease (formerly known as Fatty Liver).

The regional pharmacy team regularly updates its Pathway to Treat tool for providers, helping to guide evidence-based care.

Providence Portland Medical Center announced it will expand its emergency department to meet the growing demands of our community.

Results of a trial offered at Providence suggest some patients with rectal cancer may be treated successfully with only chemotherapy and surgery – and no radiation.

“From Awareness to Action” is the theme of the 2023 National Council on Aging’s Fall Prevention Awareness Week, recognized Sept. 17-23.

For people considering bariatric surgery as part of their journey toward better health, Providence Center for Weight Management now offers a new five-part webinar to help them understand our program.

Whether your patients are just starting a fitness routine, are competing at a high level or want to remain healthy and active, pain can be a common side effect.

Providence Oregon now offers two types of innovative treatments for adults with treatment-resistant major depression.

As part of an international consortium of cancer centers, Providence Cancer Institute is contributing to large clinical and genomic datasets that will accelerate cancer research.

Thanks to an innovative wellness pilot program, hospitalists at Providence Portland Medical Center experienced a 32% burnout rate compared to the control group’s 56%.

During the past three years, we’ve seen many manifestations and complications related to COVID-19.